Last update 16 May 2024

Iparomlimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
PD-1 monoclonal antibody
+ [1]
Target
Mechanism
PD-1 inhibitors(Programmed cell death protein 1 inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsNDA/BLA
CN
17 Sep 2023
Advanced Gastric AdenocarcinomaPhase 3
CN
01 Jul 2020
Advanced Hepatocellular CarcinomaPhase 2
CN
01 Jul 2021
Advanced cancerPhase 2
CN
08 Jul 2020
Microsatellite instability-high cancerPhase 2
CN
08 Jul 2020
Microsatellite Instability-high Solid TumorsPhase 2
CN
08 Jul 2020
Advanced Malignant Solid NeoplasmPhase 1
CN
29 May 2019
Metastatic Carcinoma to the Uterine CervixDiscovery
CN
23 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
35
(zdjfbclacx) = jyzaunxoxb gkucfqejqh (gvscfgswpx )
Positive
23 Oct 2023
Phase 1/2
76
(qwwrcwaaym) = qftrvfqwgg oyydwumkus (sdvxyhsbmz )
Positive
26 May 2023
(qwwrcwaaym) = fwuzkhdprm oyydwumkus (sdvxyhsbmz )
Biospace
ManualManual
Phase 1
35
(macsnsaumr) = epdlmlurea jvenarudah (ugmealnjdy )
Positive
06 Nov 2023
(3 mg/kg Q2W)
(eewyfrplcg) = fclwswdrjm nnlnnuwufa (mqbprqdknt )
Phase 2
120
(tdlxvekbrt) = ptciswpatk detdfeimxw (kcdhpduavs, 36.7% - 55.2)
Positive
02 Dec 2023
Phase 2/3
46
(vpnojrqhyf) = oqqnrzexqr pqfbbvmpuv (zowygqflkm )
Positive
04 Dec 2022
Phase 1
35
(ospizzqfaj) = vhdqlqfrqy kkhbeheaax (bnfzdvhgjo )
Positive
06 Mar 2023
Phase 2
46
QL1604 plus paclitaxel-cisplatin/carboplatin
qkmhuphire(knoksnirhw) = 97.8% of patients experienced treatment-related adverse events (TRAEs) tibgaqlxze (vahjjbplsx )
Positive
29 Mar 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free